Literature DB >> 32293936

Clinical Profile in Genetically Proven Blau Syndrome: A Case Series from South India.

Kalpana Babu1, Anand P Rao2.   

Abstract

Purpose: To report the clinical profile of genetically proven Blau syndrome in seven cases from a single center in South India.Materials &
Methods: Retrospective case series
Results: There were four females and three males. All cases had a history of skin and joint involvement of varying severity. Flexion contractures of the proximal interphalangeal joints were seen in all cases except Case 2. Ocular involvement was bilateral and included keratoconjunctivitis sicca (six cases), granulomatous panuveitis (three cases), granulomatous anterior uveitis (three cases), conjunctival granulomas (three cases), subepithelial corneal opacities (one case), and subretinal granuloma (one case). Other ocular findings included band-shaped keratopathy (five cases) and cataract (three cases). All cases received oral steroids and methotrexate with an addition of mycophenolate mofetil in one case. Visual prognosis was good in all cases.Conclusions: Blau syndrome is underreported in India. This is the largest case series of genetically proven Blau syndrome from South India and highlights the clinical profile of Blau syndrome seen in India.

Entities:  

Keywords:  Blau syndrome; South India; granulomatous uveitis; pediatric; subepithelial opacities

Year:  2020        PMID: 32293936     DOI: 10.1080/09273948.2020.1746353

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  5 in total

Review 1.  Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis.

Authors:  Tomoko Matsuda; Naotomo Kambe; Riko Takimoto-Ito; Yoko Ueki; Satoshi Nakamizo; Megumu K Saito; Syuji Takei; Nobuo Kanazawa
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

2.  Spectrum of Systemic Auto-Inflammatory Diseases in India: A Multi-Centric Experience.

Authors:  Deepti Suri; Amit Rawat; Ankur Kumar Jindal; Pandiarajan Vignesh; Anju Gupta; Rakesh Kumar Pilania; Vibhu Joshi; Kanika Arora; Rajni Kumrah; Gummadi Anjani; Amita Aggarwal; Shubha Phadke; Fouzia N Aboobacker; Biju George; Eunice Sindhuvi Edison; Mukesh Desai; Prasad Taur; Vijaya Gowri; Ambreen Abdulwahab Pandrowala; Sagar Bhattad; Swati Kanakia; Marco Gottorno; Isabella Ceccherini; Adriana Almeida de Jesus; Raphaela Goldbach-Mansky; Michael S Hershfield; Surjit Singh
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 7.561

3.  Blau syndrome: An under-reported condition in India?

Authors:  A Agarwal; S Karande
Journal:  J Postgrad Med       Date:  2022 Apr-Jun       Impact factor: 1.566

4.  Blau syndrome: Lessons learned in a tertiary care centre at Chandigarh, North India.

Authors:  Rajni Kumrah; Rakesh Kumar Pilania; Nitin Kumar Menia; Amit Rawat; Jyoti Sharma; Anju Gupta; Pandiarajan Vignesh; Ankur Kumar Jindal; Rashmi Rikhi; Aniruddha Agarwal; Vishali Gupta; Surjit Singh; Deepti Suri
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

5.  Bilateral Optic Disc Swelling as a Plausible Common Ocular Sign of Autoinflammatory Diseases: Report of Three Patients with Blau Syndrome or Cryopyrin-Associated Periodic Syndrome.

Authors:  Toshihiko Matsuo; Masato Yashiro; Osamu Yamasaki; Takehiro Tanaka; Akira Manki
Journal:  Life (Basel)       Date:  2021-12-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.